The information on this website is presented by the National Blood Authority (NBA) for the purpose of disseminating information for the benefit of the public.
In July and September 2017, the NBA received National Blood Supply Change Proposals for purified human alpha1-proteinase inhibitor (A1-PI) for the treatment of
